ALNY vs REGN: Which Stock is Better?
Side-by-side comparison of Alnylam Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
ALNY
Alnylam Pharmaceuticals Inc
$333.39
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | ALNY | REGN | Winner |
|---|---|---|---|
| Market Cap | $45.01B | $79.87B | REGN |
| P/E Ratio | 145.05 | 18.21 | REGN |
| EPS (TTM) | $2.34 | $41.48 | REGN |
| Revenue Growth | 0.8% | 0.0% | ALNY |
| Gross Margin | 81.6% | 44.6% | ALNY |
Analyze ALNY
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALNY or REGN a better investment?
Comparing ALNY and REGN: Alnylam Pharmaceuticals Inc has a market cap of $45.01B while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALNY and REGN?
ALNY (Alnylam Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALNY or REGN?
Based on P/E ratios, REGN trades at a lower multiple (18.2x vs 145.0x).
Which is growing faster: ALNY or REGN?
ALNY has higher revenue growth at 0.8% vs 0.0% for REGN.
Which company is more profitable: ALNY or REGN?
Alnylam Pharmaceuticals Inc (ALNY) has higher gross margins at 81.6% compared to 44.6% for REGN.
Which is the larger company: ALNY or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $45.01B for ALNY.
Should I buy ALNY or REGN in 2026?
Both ALNY and REGN have investment merit. ALNY trades at $333.39 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALNY and REGN stock?
Key differences: Market Cap ($45.01B vs $79.87B), P/E Ratio (145.0x vs 18.2x), Revenue Growth (0.8% vs 0.0%), Gross Margin (81.6% vs 44.6%).